SAFETY AND TOLERABILITY OF VANDETANIB IN JAPANESE PATIENTS WITH MEDULLARY THYROID CANCER: A PHASE I/II OPEN-LABEL STUDY

Endocrine Practice ◽

10.4158/ep161259.or ◽

2017 ◽

Vol 23 (2) ◽

pp. 149-156 ◽

Author(s):

Keita Uchino ◽

Masato Komoda ◽

Junichi Tomomatsu ◽

Takahiro Okamoto ◽

Kiyomi Horiuchi ◽

...

Keyword(s):

Thyroid Cancer ◽

Phase I ◽

Medullary Thyroid Cancer ◽

Japanese Patients ◽

Open Label Study ◽

Label Study ◽

Medullary Thyroid

Download Full-text

A phase II open-label study of vandetanib in patients with locally advanced or metastatic hereditary medullary thyroid cancer

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.6024 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 6024-6024 ◽

Author(s):

R. I. Haddad ◽

A. D. Krebs ◽

J. Vasselli ◽

L. G. Paz-Ares ◽

B. Robinson

Keyword(s):

Thyroid Cancer ◽

Phase Ii ◽

Medullary Thyroid Cancer ◽

Locally Advanced ◽

Open Label Study ◽

Label Study ◽

Medullary Thyroid ◽

Hereditary Medullary Thyroid Cancer

Download Full-text

A Phase I Open-label Study for Subjects With Advanced Malignancies

Case Medical Research ◽

10.31525/ct1-nct04136834 ◽

2019 ◽

Author(s):

Keyword(s):

Phase I ◽

Open Label Study ◽

Label Study ◽

Advanced Malignancies

Download Full-text

Guselkumab, a human interleukin-23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: Efficacy and safety analyses of a 52-week, phase 3, multicenter, open-label study

The Journal of Dermatology ◽

10.1111/1346-8138.14294 ◽

2018 ◽

Vol 45 (5) ◽

pp. 529-539 ◽

Author(s):

Shigetoshi Sano ◽

Hiroshi Kubo ◽

Hitomi Morishima ◽

Ryosuke Goto ◽

Richuan Zheng ◽

...

Keyword(s):

Monoclonal Antibody ◽

Japanese Patients ◽

Efficacy And Safety ◽

Phase 3 ◽

Open Label Study ◽

Label Study ◽

Generalized Pustular Psoriasis ◽

Erythrodermic Psoriasis ◽

Download Full-text

Pharmacokinetics of Single and Multiple Doses of Omega‐3 Carboxylic Acids in Healthy Chinese Subjects: A Phase I, Open‐Label Study

Clinical Pharmacology in Drug Development ◽

10.1002/cpdd.800 ◽

2020 ◽

Vol 9 (8) ◽

pp. 985-994

Author(s):

Shan Jing ◽

Zhenxian Zhang ◽

Xiaowen Chen ◽

Rui Miao ◽

Catarina Nilsson ◽

...

Keyword(s):

Phase I ◽

Carboxylic Acids ◽

Omega 3 ◽

Open Label Study ◽

Label Study ◽

Single And Multiple Doses ◽

Multiple Doses ◽

Healthy Chinese ◽

Chinese Subjects

Download Full-text

Safety and tolerability of sifalimumab, an anti-interferon-α monoclonal antibody, in Japanese patients with systemic lupus erythematosus: A multicenter, phase 2, open-label study

Modern Rheumatology ◽

10.1080/14397595.2019.1583832 ◽

2019 ◽

Vol 30 (1) ◽

pp. 93-100 ◽

Author(s):

Tsutomu Takeuchi ◽

Yoshiya Tanaka ◽

Ryutaro Matsumura ◽

Kazuyoshi Saito ◽

Mitsuhiro Yoshimura ◽

...

Keyword(s):

Systemic Lupus Erythematosus ◽

Lupus Erythematosus ◽

Japanese Patients ◽

Interferon Α ◽

Phase 2 ◽

Systemic Lupus ◽

Open Label Study ◽

Label Study ◽

Multicenter Phase

Download Full-text

A phase I, open-label study (EGF 100262) of lapatinib plus chemoradiation in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)

Radiotherapy and Oncology ◽

10.1016/s0167-8140(07)80091-0 ◽

2007 ◽

Vol 82 ◽

pp. S30 ◽

Author(s):

I. El-Hariry ◽

K. Harrington ◽

J. Bourhis ◽

C. Holford

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Advanced Squamous Cell Carcinoma ◽

Open Label Study ◽

Download Full-text

Erratum to: Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer

International Journal of Clinical Oncology ◽

10.1007/s10147-016-1052-3 ◽

2016 ◽

Vol 22 (1) ◽

pp. 79-79 ◽

Author(s):

Noboru Yamamoto ◽

Koichi Goto ◽

Makoto Nishio ◽

Kenichi Chikamori ◽

Toyoaki Hida ◽

...

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Egfr Mutation ◽

Japanese Patients ◽

Small Cell Lung ◽

Open Label Study ◽

Download Full-text

Abstract C37: A Phase 1 open‐label study evaluating pharmacokinetics, safety, and tolerability of linifanib in Japanese patients with solid tumors

10.1158/1535-7163.targ-09-c37 ◽

2009 ◽

Author(s):

Tomohide Tamura ◽

Noboru Yamamoto ◽

Hiroshi Nokihara ◽

Yasuhide Yamada ◽

Hajime Asahina ◽

...

Keyword(s):

Solid Tumors ◽

Phase 1 ◽

Japanese Patients ◽

Open Label Study ◽

Download Full-text

A Phase I, Randomized, Crossover, Open-label Study of the Pharmacokinetics of Solriamfetol (JZP-110) in Healthy Adult Subjects With and Without Food

Clinical Therapeutics ◽

10.1016/j.clinthera.2018.12.001 ◽

2019 ◽

Vol 41 (2) ◽

pp. 196-204 ◽

Author(s):

Katie Zomorodi ◽

Martin Kankam ◽

Yuan Lu

Keyword(s):

Phase I ◽

Healthy Adult ◽

Open Label Study ◽

Download Full-text

Long-term safety and seizure outcome in Japanese patients with Lennox–Gastaut syndrome receiving adjunctive rufinamide therapy: An open-label study following a randomized clinical trial

Epilepsy Research ◽

10.1016/j.eplepsyres.2016.01.002 ◽

2016 ◽

Vol 121 ◽

pp. 1-7 ◽

Author(s):

Yoko Ohtsuka ◽

Harumi Yoshinaga ◽

Yukiyoshi Shirasaka ◽

Rumiko Takayama ◽

Hiroki Takano ◽

...

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Japanese Patients ◽

Seizure Outcome ◽

Open Label Study ◽

Download Full-text